Landor, the brand specialist agency from the WPP network, has partnered with Invengene, a pharmaceutical brand. 

The agency will be responsible for the brand's revived identity including brand positioning, voice and visual identity. 

With a focus on precision, innovation, and strategic action, Landor has crafted a distinct and recognisable identity that reflects the brand’s role in accelerating growth while the logo reflects their dedication to precision and innovation.

The collaboration between Landor and Invengene signals a new chapter for the pharmaceutical industry, where design innovation meets purpose to drive meaningful change and growth.

A key highlight of the collaboration is the introduction of CalMarks, a signature element that embodies precision and reliability in every Invengene product. The three Ns in 'Invengene' symbolise the brand's commitment to innovation, quality, and customer satisfaction.

Invengene’s founders said, "The injectables industry is complex, which often hampers both effective healthcare and category advancement. There was an opportunity for Invengene to step in to solve this jigsaw. Fuelled by Landor’s strategic vision and creative expertise, our new vision-driven identity showcases precision and reliability in every solution making us poised to lead the way in revolutionising the injectables market. Our partnership with Landor exemplifies a synergistic collaboration driving innovation in the pharmaceutical landscape.”

Ronita Mukerjee, executive director - client services, Landor India, said, “Through a purpose-driven brand positioning and a unique brand identity; we were able to help Invengene stand out and stand for something in a very cluttered category. We are proud to have played a role in elevating Invengene as a dynamic growth catalyst in the injectables space."